21 | Liposomes (Liposome)IBA
02/2021
-
05/2007 |
14 | Radioisotopes (Radionuclides)IBA
05/2021
-
11/2008 |
7 | Peptides (Polypeptides)IBA
05/2021
-
10/2010 |
5 | Therapeutic UsesIBA
04/2021
-
07/2005 |
4 | RadiopharmaceuticalsIBA
05/2021
-
10/2009 |
4 | Melanins (Melanin)IBA
09/2020
-
05/2015 |
4 | Rhenium-188IBA
01/2018
-
10/2012 |
4 | Saline SolutionIBA
01/2017
-
03/2012 |
4 | liposomal doxorubicin (Doxil)FDA Link
10/2014
-
11/2008 |
3 | Coloring Agents (Dyes)IBA
05/2021
-
01/2006 |
3 | ErbB Receptors (EGF Receptor)IBA
02/2021
-
08/2019 |
3 | MicroRNAs (MicroRNA)IBA
08/2020
-
10/2016 |
3 | Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2020
-
01/2012 |
3 | Fluorouracil (Carac)FDA LinkGeneric
08/2013
-
01/2011 |
3 | Vinorelbine (Navelbine)FDA LinkGeneric
01/2012
-
08/2009 |
3 | Glucose (Dextrose)FDA LinkGeneric
01/2011
-
03/2006 |
2 | Dihydrotachysterol (AT 10)IBA
03/2022
-
01/2012 |
2 | Pentetic Acid (DTPA)FDA LinkGeneric
03/2022
-
08/2009 |
2 | cyclic (arginyl- glycyl- aspartyl- phenylalanyl- lysyl)IBA
05/2021
-
01/2021 |
2 | IntegrinsIBA
05/2021
-
01/2021 |
2 | Evans Blue (Blue, Evans)FDA Link
05/2021
-
01/2017 |
2 | Proteins (Proteins, Gene)FDA Link
04/2021
-
07/2005 |
2 | LigandsIBA
01/2020
-
12/2019 |
2 | Cell-Penetrating PeptidesIBA
01/2020
-
12/2019 |
2 | Irinotecan (Camptosar)FDA LinkGeneric
01/2020
-
12/2019 |
2 | Human Serum AlbuminFDA LinkGeneric
05/2018
-
05/2015 |
2 | Serum AlbuminIBA
05/2018
-
01/2017 |
2 | Doxorubicin (Adriamycin)FDA LinkGeneric
06/2011
-
12/2008 |
2 | Drug CarriersIBA
06/2011
-
08/2009 |
2 | BombesinIBA
10/2010
-
08/2009 |
2 | Bombesin Receptors (Bombesin Receptor)IBA
10/2010
-
08/2009 |
1 | ChitosanIBA
03/2022 |
1 | Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021 |
1 | AntioxidantsIBA
11/2021 |
1 | Chelating AgentsIBA
05/2021 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
05/2021 |
1 | arginyl-glycyl-aspartic acidIBA
05/2021 |
1 | human IL15 proteinIBA
04/2021 |
1 | Interleukin-15 (Interleukin 15)IBA
04/2021 |
1 | AlbuminsIBA
04/2021 |
1 | Nanoparticle Drug Delivery SystemIBA
04/2021 |
1 | Fcy-hEGF fusion proteinIBA
02/2021 |
1 | Epidermal Growth Factor (EGF)IBA
02/2021 |
1 | Flucytosine (Ancobon)FDA Link
02/2021 |
1 | Cytosine DeaminaseIBA
02/2021 |
1 | AnthracyclinesIBA
01/2021 |
1 | RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2021 |
1 | Epirubicin (Ellence)FDA LinkGeneric
01/2021 |
1 | benzamideIBA
09/2020 |
1 | SP90 peptideIBA
07/2020 |
1 | Lipid NanoparticlesIBA
01/2020 |
1 | GoldIBA
01/2020 |
1 | Phenobarbital (Luminal)FDA Link
01/2020 |
1 | 6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
01/2020 |
1 | SilverIBA
01/2020 |
1 | Galectin 1 (LGALS1)IBA
12/2019 |
1 | 1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA
12/2019 |
1 | A-Form DNA (A-DNA)IBA
12/2019 |
1 | CateninsIBA
12/2019 |
1 | Cetuximab (Erbitux)FDA Link
10/2019 |
1 | AfatinibIBA
08/2019 |
1 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2019 |
1 | 1- (3',4'- dichloro- 2- fluoro(1,1'- biphenyl)- 4- yl)cyclopropanecarboxylic acidIBA
01/2017 |
1 | Neuroprotective AgentsIBA
01/2017 |
1 | N2- ((2S)- 2- (3,5- difluorophenyl)- 2- hydroxyethanoyl)- N1- ((7S)- 5- methyl- 6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- L- alaninamideIBA
01/2017 |
1 | Gamma Secretase Inhibitors and ModulatorsIBA
01/2017 |
1 | Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2017 |